# Comparison Between the Efficacy of EFR and CASL in the Treatment of Small Gastric Stromal Tumors: A Retrospective Study

**Authors:** Liang Ye, Binbin Huang, Xiaoyuan Yi, Huaiyang Cai

PMC · DOI: 10.5152/tjg.2025.24461 · 2025-06-16

## TL;DR

This study compares two endoscopic techniques for treating small stomach tumors and finds one to be more efficient and cost-effective.

## Contribution

The study provides a comparative analysis of EFR and CASL for small gastric stromal tumors in elderly patients.

## Key findings

- EFR had longer operative and resection times compared to CASL.
- CASL was associated with lower hospitalization costs and shorter antibiotic use.
- CASL is more suitable for tumors in the gastric fundus and body in elderly patients.

## Abstract

This study aimed to assess the efficacy and safety of endoscopicfull-thickness resection (EFR) in comparison to cap-aspiration lumpectomy (CASL) for treating small gastrointestinal (GI) stromal tumors (GISTs).

A retrospective analysis was carried out on the data from elderly patients (66 cases) with small gastric GISTs who were treated with EFR (41 cases) or CASL (25 cases). The study compared the clinical features, surgical conditions, intraoperative and postoperative complications, postoperative efficacy, economic benefits, and follow-up of small gastric GISTs in the EFR and CASL groups.

The mean operative time for the EFR group was longer than that for the CASL group [45.0 (32.5, 66.5) minutes versus 30.0 (20.0, 42.5) minutes]; the resection time in the EFR group was higher than that in the CASL group [30.0 (20.0, 50.5) versus 9.0 (6.5, 16.5) minutes]; the rate of utilization of hot hemostatic forceps in the EFR cohort was higher than that observed in the CASL cohort [75.6% (31/41) versus 12.0% (3/25)]; the postoperative course of antibiotics was longer in the EFR group than in the CASL group [(2.8 ± 2.0) d versus (1.0 ± 2.0) d]; and the hospitalization cost of the EFR group was extremely higher than that of the CASL group [(¥13 595.0 ± 2653.3) versus (¥11 209.0 ± 2458.9)].

EFR and CASL are safe and effective in the treatment of small gastric GISTs, and CASL is more suitable for the treatment of small gastric GISTs located in the gastric fundus and body in elderly patients.

## Linked entities

- **Diseases:** gastrointestinal stromal tumors (MONDO:0011719)

## Full-text entities

- **Diseases:** gastric GISTs (MESH:D013272), Gastric Stromal Tumors (MESH:D046152)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12824896/full.md

---
Source: https://tomesphere.com/paper/PMC12824896